Castellsagué Xavier, Drudis Teresa, Cañadas Maria Paz, Goncé Anna, Ros Ramón, Pérez José M, Quintana M Jesús, Muñoz Jesús, Albero Ginesa, de Sanjosé Silvia, Bosch F Xavier
Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Program (CERP), IDIBELL - Institut Català d'Oncologia (ICO), Hospitalet de Llobregat, Barcelona, Spain.
BMC Infect Dis. 2009 May 27;9:74. doi: 10.1186/1471-2334-9-74.
Studies on HPV infection in pregnant women and HPV transmission to the child have yielded inconsistent results.
To estimate mother-to-child HPV transmission we carried out a prospective cohort study that included 66 HPV-positive and 77 HPV-negative pregnant women and their offspring attending a maternity hospital in Barcelona. To estimate HPV prevalence and genotype distribution in pregnancy we also carried out a related screening survey of cervical HPV-DNA detection among 828 pregnant women. Cervical cells from the mother were collected at pregnancy (mean of 31 weeks) and at the 6-week post-partum visit. Exfoliated cells from the mouth and external genitalia of the infants were collected around birth, at the 6-week post-partum visit, and around 3, 6, 12, and 24 months of age. All samples were tested for HPV using PCR. Associations between potential determinants of HPV infection in pregnant women and of HPV positivity in infants were also explored by logistic regression modelling.
Overall cervical HPV-DNA detection in pregnant women recruited in the HPV screening survey was 6.5% (54/828). Sexual behavior-related variables, previous histories of genital warts or sexually transmitted infections, and presence of cytological abnormalities were statistically significantly and positively associated with HPV DNA detection in pregnant women recruited in the cohort. At 418 infant visits and a mean follow-up time of 14 months, 19.7% of infants born to HPV-positive mothers and 16.9% of those born to HPV-negative mothers tested HPV positive at some point during infants' follow-up. The most frequently detected genotype both in infants and mothers was HPV-16, after excluding untyped HPV infections. We found a strong and statistically significant association between mother's and child's HPV status at the 6-week post-partum visit. Thus, children of mothers' who were HPV-positive at the post-partum visit were about 5 times more likely to test HPV-positive than children of corresponding HPV-negative mothers (p = 0.02).
This study confirms that the risk of vertical transmission of HPV genotypes is relatively low. HPV persistence in infants is a rare event. These data also indicate that vertical transmission may not be the sole source of HPV infections in infants and provides partial evidence for horizontal mother-to-child HPV transmission.
关于孕妇人乳头瘤病毒(HPV)感染及HPV母婴传播的研究结果并不一致。
为评估HPV母婴传播情况,我们开展了一项前瞻性队列研究,纳入了巴塞罗那一家妇产医院的66名HPV阳性和77名HPV阴性孕妇及其后代。为评估孕期HPV感染率及基因型分布,我们还对828名孕妇进行了一项相关的宫颈HPV-DNA检测筛查调查。在孕期(平均31周)及产后6周访视时采集母亲的宫颈细胞。在出生前后、产后6周访视时以及3、6、12和24月龄左右采集婴儿口腔和外生殖器的脱落细胞。所有样本均采用聚合酶链反应(PCR)检测HPV。还通过逻辑回归模型探讨了孕妇HPV感染潜在决定因素与婴儿HPV阳性之间的关联。
在HPV筛查调查中招募的孕妇中,宫颈HPV-DNA总体检测率为6.5%(54/828)。在队列研究中招募的孕妇中,与性行为相关的变量、既往尖锐湿疣或性传播感染病史以及细胞学异常的存在与HPV DNA检测在统计学上显著正相关。在418次婴儿访视中,平均随访时间为14个月,HPV阳性母亲所生婴儿中有19.7%,HPV阴性母亲所生婴儿中有16.9%在婴儿随访期间的某个时间点检测出HPV阳性。在排除未分型HPV感染后,婴儿和母亲中最常检测到的基因型均为HPV-16。我们发现在产后6周访视时,母亲和孩子的HPV状态之间存在强烈且具有统计学意义的关联。因此,产后访视时HPV阳性母亲的孩子检测出HPV阳性的可能性是相应HPV阴性母亲孩子的5倍左右(p = 0.02)。
本研究证实HPV基因型垂直传播的风险相对较低。HPV在婴儿中持续存在是罕见事件。这些数据还表明垂直传播可能不是婴儿HPV感染的唯一来源,并为HPV母婴水平传播提供了部分证据。